Dengue: EMA committee endorses vaccine candidate from age 4
If definitively approved, the vaccine manufactured by Japanese pharmaceutical Takeda will be the second in the world against dengue fever
14/11/2022
If definitively approved, the vaccine manufactured by Japanese pharmaceutical Takeda will be the second in the world against dengue fever
14/11/2022Professor Lee W. Riley based EPIMOL on a discipline he taught at the University of California
14/11/2022Renowned researchers from Brazil and other countries discuss topics of great relevance in health in satellite events held simultaneously with MEDTROP
14/11/2022Acinetobacter baumannii (AB) usually causes nosocomial infections and is a rare cause of community-acquired pneumonia (CAP)
14/11/2022